Table 3.
Solutions for the cancer vs human problem
| # | Drugs | Side effect |
|---|---|---|
| 1 |
Floxuridine (#20) |
1 |
| 2 |
Mycophenolic acid (#42) |
4 |
| 3 |
Trimethoprim (#29) |
5 |
| 4 |
Methotrexate (#11) |
5 |
| 5 |
Atovaquone (#69) |
6 |
| 6 |
Tyloxapol (#85) |
6 |
| 7 |
Ezetimibe (#56) |
12 |
| 8 |
Pemetrexed (#41) |
15 |
| 9 |
Ribavirin (#51) |
17 |
| 10 |
Quinacrine (#36) |
22 |
| 11 |
Myo-Inositol (#82) |
29 |
| 12 |
Tioconazole (#60) |
34 |
| 13 |
Naftifine (#43) |
34 |
| 14 |
Simvastatin (#4) |
42 |
| 15 |
Leflunomide (#66) |
42 |
| 16 |
Auranofin (#59) - Fomepizole (#75) |
47 |
| 17 |
Indomethacin (#22) |
48 |
| 18 |
Diclofenac (#35) |
55 |
| 19 |
Hydroxyurea (#16) |
56 |
| 20 |
Arsenic trioxide (#72) |
56 |
| 21 | Gemcitabine (#30) | 99 |
We report the solutions and the side effects σ(D) for the inhibition with approved drugs. Drug numbers refer to Additional file 1: Table S1. Bold font indicates that the solution has an experimental validation.